Company Overview:
viridian therapeutics inc - VRDN
VRDN Key Data
| Open $19.66 | Day Range 18.89 - 19.72 |
| 52 Week Range 13.19 - 34.29 | Market Cap $1.99B |
| Shares Outstanding 110.43M | Public Float 102.50M |
| Beta 0.90 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$3.76 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.83M |
|
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | BUY | | Average Target Price | 36.125 |
| Number of Ratings | 17 | | Current Quarters Estimate | -0.945 |
| FY Report Date | 09 / 2026 | | Current Year's Estimate | -3.81 |
| Last Quarter’s Earnings | -1.019 | | Median PE on CY Estimate | N/A |
| Year Ago Earnings | -3.32 | | Next Fiscal Year Estimate | -2.493 |
| | | Median PE on Next FY Estimate | N/A |
Earnings Per Share
|
This Quarter
|
Next Quarter
|
This Fiscal
|
Next Fiscal
|
| # of Estimates | 14 | 14 | 15 | 15 |
| Mean Estimate | -0.94 | -0.94 | -3.81 | -2.49 |
| High Estimates | -0.37 | -0.71 | -3.26 | -1.27 |
| Low Estimate | -1.33 | -1.32 | -4.72 | -4.19 |
| Coefficient of Variance | -22.91 | -20.12 | -12.29 | -29.45 |
Analysts Recommendations
|
Current
|
1 Month Ago
|
3 Months Ago
|
| BUY |
17
|
17
|
16
|
| OVERWEIGHT |
0
|
0
|
0
|
| HOLD |
0
|
0
|
1
|
| UNDERWEIGHT |
0
|
0
|
0
|
| SELL |
0
|
0
|
0
|
| MEAN |
Buy
|
Buy
|
Buy
|
Insider Actions for Viridian Therapeutics Inc - VRDN
| Date | Name | Shares | Transaction | Value |
|
Oct 28, 2025
| Fairmount Funds Management LLC Director |
3,914,458
| Open market or private purchase of non-derivative security Non-derivative transaction at $22 per share |
86,118,076.00
|